Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
Share sale achieved a tight discount of 2.3% -
IPO volumes on the London Stock Exchange fell to levels not seen since the global financial crisis levels in 2023
-
MDs in Germany join after 17 senior hires in the US over 16 months
-
The Italian maker of luxury gym equipment rose over 7% in trading on Friday following the Saudi entry into the stock
-
Euro primary continues pumping out trades with JDE Peet's and Covivio lining up
-
Swiss pharma company navigates a difficult market to pay a negative to zero new issue premium
